# US 2012/0252906 A1 · Bioavailability Enhancement Delivery Composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252906 A1
- Document ID: US20120252906A1
- Status: Published application
- Kind: A1
- Application number: 13/308,331
- Filed: 2011-11-30
- Published: 2012-10-04
- Earliest claimed: 2010-10-18
- Assignees: PruGen IP Holdings, Inc.
- Inventors: Bhiku G. Patel
- Web page: https://patentgrep.com/patent/US20120252906A1

## CPC

- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 9/4858: {Organic compounds}
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A composition for increasing the bioavailability of an active pharmaceutical ingredient (“API”) in humans and animals, comprising a first water soluble surfactant having a cloud point greater than about 37° C., a second water soluble surfactant having a cloud point greater than about 37° C., wherein a mixture of the first surfactant and the second surfactant comprises a cloud point less than about 37° C.

## Claims

### Claim 1

A composition for increasing the bioavailability of an active pharmaceutical ingredient (“API”) in humans and animals, comprising:
a first water soluble surfactant having a cloud point greater than about 37° C.;
a second water soluble surfactant having a cloud point greater than about 37° C.;
wherein a mixture of said first surfactant and said second surfactant comprises a cloud point less than about 37° C.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising a water-insoluble compound.

### Claim 3 (depends on 2)

The composition of claim 2, wherein a weight ratio of said mixture and said non-water soluble compound is between about 99:1 to about 9:1.

### Claim 4 (depends on 3)

The composition of claim 3, wherein a weight ratio of said mixture and said non-water soluble compound is about 12:1.

### Claim 5 (depends on 2)

The composition of claim 2, wherein said non-water soluble compound comprises a triglyceride.

### Claim 6 (depends on 2)

The composition of claim 2, wherein said non-water soluble compound comprises one or more terpenes.

### Claim 7 (depends on 1)

The composition of claim 1, wherein a weight ratio of said first surfactant and said second surfactant is between about 1:1 to about 4:1.

### Claim 8 (depends on 7)

The composition of claim 7, wherein a weight ratio of said first surfactant and said second surfactant is about 2:1.

### Claim 9 (depends on 1)

The composition of claim 1, wherein said first surfactant comprises polyoxyethylene sorbitan monooleate.

### Claim 10 (depends on 9)

The composition of claim 9, wherein said second surfactant is tocopheryl polyethylene glycol succinate.

### Claim 11 (depends on 1)

The composition of claim 1, wherein said first surfactant and said second surfactant have individual HLB values in the range of about 10 to about 30.

### Claim 12 (depends on 1)

The composition of claim 1, wherein said first surfactant and said second surfactant have individual HLB values in the range of about 12 to about 18.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the first surfactant and second surfactant, when in combination, have an HLB value in the range of about 14 to about 14.6.

### Claim 14 (depends on 1)

The composition of claim 1, further comprising:
a third surfactant having a cloud point greater than about 37° C.;
wherein a mixture of said first surfactant, said second surfactant, and said third surfactant comprises a cloud point less than about 37° C.

### Claim 14 (depends on 1)

The composition of claim 1, further including a solubilizing agent.

### Claim 15 (depends on 14)

The composition of claim 14, wherein said solubilizing agent is selected from the group consisting of polyethylene glycol, propylene glycol, a fatty acid, a fatty ester, ethoxylated fatty acids, and ethoxylated fatty alcohols.

### Claim 16

A composition for increasing the bioavailability of an active pharmaceutical ingredient (“API”) in humans and animals, formed by the process of:
mixing a first water soluble surfactant having a cloud point greater than about 37° C. with a second water soluble surfactant having a cloud point greater than about 37° C.;
wherein the mixture of said first surfactant and said second surfactant comprises a cloud point less than about 37° C.

### Claim 17 (depends on 16)

The composition of claim 16, wherein the process further comprises adding a water-insoluble compound to said mixture of said first surfactant and said second surfactant.

### Claim 18 (depends on 17)

The composition of claim 17, wherein a weight ratio of said mixture and said water-insoluble compound is between about 99:1 to about 9:1.

### Claim 19 (depends on 18)

The composition of claim 18, wherein a weight ratio of said mixture and said non-water soluble compound is about 12:1.

### Claim 20 (depends on 17)

The composition of claim 17, wherein said non-water soluble compound comprises a triglyceride.

### Claim 21 (depends on 17)

The composition of claim 17, wherein said non-water soluble compound comprises a terpene.

### Claim 22 (depends on 16)

The composition of claim 16, wherein a weight ratio of said first surfactant and said second surfactant is between about 1:1 to about 4:1.

### Claim 23 (depends on 22)

The composition of claim 22, wherein a weight ratio of said first surfactant and said second surfactant is about 2:1.

### Claim 24 (depends on 16)

The composition of claim 16, wherein said first surfactant comprises polyoxyethylene sorbitan monooleate.

### Claim 25 (depends on 24)

The composition of claim 24, wherein said second surfactant is tocopheryl polyethylene glycol succinate.

### Claim 26 (depends on 16)

The composition of claim 16, wherein said first surfactant and said second surfactant have individual HLB values in the range of about 10 to about 30.

### Claim 27 (depends on 26)

The composition of claim 26, wherein said first surfactant and said second surfactant have individual HLB values in the range of about 12 to about 18.

### Claim 28 (depends on 27)

The composition of claim 27, wherein the first surfactant and second surfactant, when in combination, have an HLB value in the range of about 14 to about 14.6.

### Claim 29 (depends on 16)

The composition of claim 16, wherein said process further comprises:
adding a third surfactant having a cloud point greater than about 37° C.;
wherein a mixture of said first surfactant, said second surfactant, and said third surfactant comprises a cloud point less than about 37° C.

### Claim 30 (depends on 16)

The composition of claim 16, said process comprising adding a solubilizing agent.

### Claim 31 (depends on 30)

The composition of claim 30, wherein said solubilizing agent is selected from the group consisting of polyethylene glycol, propylene glycol, a fatty acid, a fatty ester, ethoxylated fatty acids, and ethoxylated fatty alcohols.
